NewsRoom Articles - Page 169 of 226

MondayJun 07, 2021 12:19 pm

Brain Scientific Inc. (BRSF) Expands Commercialization of its Pediatric NeuroCap(TM); Announces Maine Medical Center Has Placed Order

BRSF announced that Maine Medical Center, a teaching hospital providing health care across Portland, Maine, and northern New England, has placed an order for Pediatric NeuroCap(TM), Company's pediatric disposable EEG headset. EEG testing is increasingly needed in pediatric patients, where neurological workup faces even bigger challenges than in adults. BRSF has developed disposable EEG caps for adults and children to meet the needs of the pediatric neuro testing market; partners with medical facilities to expand its unique technology and respond to unmet market need. Brain Scientific (OTCQB: BRSF), a commercial-stage healthcare technology company developing solutions in the brain diagnostics space,…

FridayJun 04, 2021 11:39 am

Contrast-Enhanced MRI’s May Better Traumatic Brain Injury Diagnosis

Growing public attention on the traumatic brain injuries that football players suffer while playing the sport has led to various studies on the topic being conducted. Among them is a study conducted last year and approved by the institutional review board of the Soroka University Medical Center. The study recruited 26 nonathletes, 27 athletes who played a noncontact sport and 42 amateur American football players to participate in the study. All the participants gave their informed consent to be part of the study, with the first two groups being classified under the control group. The investigators’ primary goal was to…

FridayJun 04, 2021 9:15 am

Brain Scientific Inc. (BRSF) Poised to Solve Major Obstacles to Neurological Testing in Pediatric Patients

There is a significant need for EEG diagnostics in pediatric patients, but traditional testing is challenging due to poorly fitting adult-sized equipment, which also increases resistance to testing This leaves a considerable gap in neurological care for young patients BRSF’s Pediatric NeuroCap steps in to solve major barriers limiting EEG monitoring in pediatric care There is a significant need for EEG diagnostics in pediatric patients, as children can suffer from neurological conditions, but traditional EEG procedure in this setting is time-consuming, cumbersome, and inconvenient. It means that the benefits of EEG testing in pediatrics could not be fully leveraged, leaving…

FridayJun 04, 2021 9:15 am

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Working to Make Blue Light Cystoscopy Easier to Use and More Accessible to Hospitals and Patients at a Lower Cost

Imagin Medical Inc. has designed a system to improve the visualization of bladder cancer during minimally invasive surgery that will display, simultaneously, white and blue light images side-by-side, to help surgeons more easily identify and locate cancerous tumors for removal The company’s i/Blue Imaging System(TM) has the potential to make bladder cancer detection and removal more efficient and accurate, as well as reduce recurrence rates and health care costs, targeting a global bladder cancer market estimated to reach $4.71 billion by 2026 The company’s proprietary system has entered the manufacturing stage with their partner Lighthouse Imaging, an FDA registered and…

ThursdayJun 03, 2021 2:00 pm

Researchers Discover Link Between Alzheimer’s, BMI

A recent study conducted by researchers from Ohio State University has found that a higher BMI doesn’t necessarily increase an individual’s chance of developing Alzheimer’s disease. This is despite the fact that obesity in mid-life has been associated with a higher risk of Alzheimer’s. For their research, the scientists compared data obtained from two groups of individuals who had been diagnosed with mild cognitive impairment. One group’s disease didn’t worsen while the other’s condition progressed to Alzheimer’s within two years. The scientists focused on two factors: various genetic variants that have been linked to Alzheimer’s and body mass index (“BMI”).…

ThursdayJun 03, 2021 9:00 am

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Targets Academic Collaborations to Advance Research on Largely Ignored Indications for Psilocybin

Psychedelics have been on the receiving end of groundbreaking research, which have greatly influenced the medical acceptance of the compounds Pharmaceutical developer Tryp Therapeutics is looking to use existing preclinical and clinical data to proceed directly to Phase 2a clinical trials The company intends to contribute to the growing body of research through academic collaborations with leading American institutions The research will focus on indications that other pharmaceutical companies have largely ignored Although we can accurately describe the psychedelics industry as nascent, psychedelics have been the subject of a flurry of groundbreaking research that have gradually lifted the stigma surrounding…

WednesdayJun 02, 2021 2:32 pm

New Immunotherapy May Improve Stroke Recovery

A recent study conducted by neurologists from the School of Medicine at the University of Pittsburg has discovered that immune cells that amass in the brain following a stroke help boost neural functions, as observed in mice models. The research, which was reported in the “Immunity” journal, showed that regulatory T cells, which are specialized immune cells, help boost functional recovery following a stroke. The researchers stated that boosting the regulatory T cell levels through the use of an antibody complex treatment enhanced cognitive and behavioral functions in mice following a stroke. This was in comparison to the mice that…

WednesdayJun 02, 2021 9:30 am

Healthy Extracts Inc. (HYEX) Using HERHEART(TM) Supplement to Address the Cardiovascular Disease Headache among Women

Cardiovascular disease is the leading cause of mortality among women globally and in the US Using this knowledge as the motivation, Healthy Extracts, through its wholly owned subsidiary BergaMet NA, developed HERHEART(TM) HERHEART is derived from the bergamot fruit, richly packed with polyphenols, and is formulated specifically for women to improve heart health and perimenopausal symptoms Polyphenols have antioxidant and anti-inflammatory properties and are associated with improved heart health, as well as the prevention of some heart-related conditions Through HERHEART product, Healthy Extracts is playing a vital preventative role in the fight against cardiovascular disease among women Cardiovascular disease is…

WednesdayJun 02, 2021 9:15 am

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Beginning 2021 Strong with New Drugs and Life Sciences Advancements

Promising results have been recorded in the first pilot study of a Rotigotine skin patch for Parkinson’s patients Wholly owned subsidiary Vektor is reaching a major milestone in the development of Rotigotine with the potential for a pivotal human trial The company is planning the construction of a new lab and manufacturing space up to 32,000 square feet in Biberach, Germany Pilot project involving rapid COVID-19 PCR tests has been initiated in Germany, promising efficacy and accuracy of results in as little as 25 minutes XPhyto is currently in talks and negotiations with distribution and wholesale partners, with a potential…

TuesdayJun 01, 2021 1:00 pm

Mathematical Models Show COVID-19 May Become Seasonal Virus Within a Decade

Recent research conducted by researchers from the University of Utah has found that in the next 10 years, the SARS-CoV-2 virus, which is responsible for the coronavirus, may cause no more than sniffles and coughs similar to the common cold. The researchers used mathematical models to predict how the body’s immunity changes over time. Their findings were reported in the “Viruses” journal. Fred Adler, a professor of biological sciences and mathematics at the institution, explained that the models demonstrated a possible future that is yet to be addressed fully. He added that as people collectively develop immunity over the next…

News and publishing service for medical and biotechnology related companies

Contact us: 512.354.7000

Brain Scientific Inc. (BRSF) Expands Commercialization of its Pediatric NeuroCap(TM); Announces Maine Medical Center Has Placed Order

Contrast-Enhanced MRI’s May Better Traumatic Brain Injury Diagnosis

Brain Scientific Inc. (BRSF) Poised to Solve Major Obstacles to Neurological Testing in Pediatric Patients

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Working to Make Blue Light Cystoscopy Easier to Use and More Accessible to Hospitals and Patients at a Lower Cost

Researchers Discover Link Between Alzheimer’s, BMI

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Targets Academic Collaborations to Advance Research on Largely Ignored Indications for Psilocybin

New Immunotherapy May Improve Stroke Recovery

Healthy Extracts Inc. (HYEX) Using HERHEART(TM) Supplement to Address the Cardiovascular Disease Headache among Women

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Beginning 2021 Strong with New Drugs and Life Sciences Advancements

Mathematical Models Show COVID-19 May Become Seasonal Virus Within a Decade

Official NewsWire Relationships

BioMedWire Currently Accepts

BioMedWire

Company Search

Site Search